IAVI and Biofabri are collaborating on the trial, which will recruit around 4,300 patients with latent TB infections across ...

The bacterium chlamydia trachomatis is a major cause of sexually transmitted diseases. Bacteria have lots of tricks up their ...

Imunon has reported new immunogenicity and safety data from its proof-of-concept Phase I trial’s ongoing analyses of the IMNN ...

The ability to control gene expression across a wide range is crucial for many fields, including bioengineering, disease ...